Invention Grant
- Patent Title: Pharmaceutical preparation comprising supernatant of blood mononuclear cell culture
-
Application No.: US13140097Application Date: 2009-12-18
-
Publication No.: US11235003B2Publication Date: 2022-02-01
- Inventor: Hendrik Jan Ankersmit
- Applicant: Hendrik Jan Ankersmit
- Applicant Address: AT Vienna
- Assignee: Hendrik Jan Ankersmit
- Current Assignee: Hendrik Jan Ankersmit
- Current Assignee Address: AT Vienna
- Agency: Workman Nydegger
- Priority: EP08450198 20081218
- International Application: PCT/EP2009/067534 WO 20091218
- International Announcement: WO2010/079086 WO 20100715
- Main IPC: A61K35/14
- IPC: A61K35/14 ; A61K35/17 ; A61K35/16
Abstract:
The present invention relates to a topical pharmaceutical preparation for treating an inflammatory skin condition, preferably a condition associated with ischemia, comprising a supernatant of a physiological solution obtainable by cultivating peripheral blood mononuclear cells (PBMCs) or a subset thereof in a physiological solution free of PBMC-proliferating and PBMC-activating substances for at least 1 h.
Public/Granted literature
- US20120045418A1 PHARMACEUTICAL PREPARATION COMPRISING SUPERNATANT OF BLOOD MONONUCLEAR CELL CULTURE Public/Granted day:2012-02-23
Information query
IPC分类:
